FACULTY DISCLOSURES

As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Yves Fradet, MD, FRCSC Consultant: AstraZeneca Pharmaceuticals LP Stock Shareholder: DiagnoCure Inc Raju Thomas, MD, FACS, MHA Grants/Research Support: Intuitive Surgical Inc Consultant: Boehringer Ingelheim GmbH, Intuitive Surgical Inc Stock Shareholder: Bristol-Myers Squibb Company, Merck and Company Inc	Susan F Slovin, MD, PhD Consultant: Synarc Speakers Bureau: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Bristol-Myers Squibb Company, Novartis Pharmaceuticals
	Joel Picus, MD Grants/Research Support: Pfizer Inc Consultant: Genentech BioOncology

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.